Is FGL-L FDA approved?
No. This profile records FGL-L as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE SYNAPSE ENHANCER
Neural Cell Adhesion Molecule-derived FGL peptide
FGL-L is a synthetic peptide that mimics neural cell adhesion molecule (NCAM), a protein crucial for brain cell communication and plasticity. It activates growth factor receptors to promote synapse formation, enhance memory, and protect neurons.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records FGL-L as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: Research dosing varies.
No established human protocol. Schedule: daily. Cycle: As needed for research. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Activates fibroblast growth factor receptors for brain growth
Increases AMPA receptor availability for stronger connections
Protects neurons from damage and degeneration
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.